5. Case History
• 32 yr old woman, T1 DM, 30 weeks pregnant. Had been
unwell with dysuria and vague abdominal pain and felt
nauseous.
• Presented to the obstetric day unit where she was found to be
slightly breathless and mildly febrile (37.9 ° C), and urinalysis
showed 3+ ketones, trace proteinuria and glycosuria 55
mmol/L (990 mg/dL). Her CBG was 11.9 mmol/L (214 mg/dL).
• A diagnosis of UTI was made, commenced on oral cefalexin
and discharged.
• 12 hrs later, brought to the ER, severely breathless & vomiting
with severe abdominal pain. O/E: pulse 120/min, regular,
hypotensive (BP 90/50 mmHg lying, 70/40 mmHg sitting),
dehydrated and unwell. Laboratory plasma glucose was 35.6
mmol/L (641 mg/dL), blood 3 - hydroxybutyrate was 8.1
mmol/L. Arterial pH was 7.0.
14. Goals of Therapy
1. Reduction of
hyperglycemia
2. Rehydration
3. Correction of electrolyte
imbalance
4. Correction of acid-base
imbalance
5. Investigation of
precipitating factors,
treatment of
complications.
17. Protocol for management in patients <20 yrs
AmericanDiabetesAssociationDiaCare2004;27:s94-s102
18. Case History
• 60 year old male T2 DM on Sitagliptin and
Metformin
• 3 week history of polyuria, weight loss and
diminished oral intake; H/o CVA 2 months back
• No history of nausea, vomiting, tachypnea
• Presented with mental confusion and lethargy
• O/E: Pulse 120/min; BP 90/50 mm Hg; Tongue
dry
• CBG >600 mg/dL; Arterial pH 7.32
20. Pathophysiology
• Relative insulin deficiency and inadequate fluid
intake
• Increased hepatic glucose production and
impaired glucose utilization in skeletal muscle
• Lower levels of counter-regulatory hormones
and free fatty acids
• Insulin/glucagon ratio does not favor ketogenesis
21. Predisposing Factors
1. Spontaneous occurrence in 5 – 7 % of patients.
2. Infection: pneumonia, UTI, Gm -ve sepsis
3. Drugs: steroids increase glucogenesis;
• potassium-wasting diuretics (hypokalemia
decreases insulin secretion), e.g., thiazides,
furosemide;
• other drugs, e.g., propranolol, azathioprine,
diazoxide.
5. Misc: CVA, SDH, acute pancreatitis, severe
burns
6. Use of conc. glucose solutions, such as used in
peripheral hyperalimentation or renal dialysis
7. Peritoneal or hemodialysis, tube feeding.
22. Clinical Manifestations
• Mental confusion, lethargy or coma
• Profound dehydration
• Hypotension, tachycardia
• Notably absent are symptoms of nausea,
vomiting, abdominal pain and the
Kussmaul respirations (characteristic of
DKA)
27. Causes
TYPE A
Poor tissue perfusion
• Shock, Cardiac failure
• Severe anemia
• Mitochondrial enzyme
defects
• Inhibitors (Cyanide, CO)
TYPE B
Aerobic disorders
• DM
• Malignancies
• NRTIs
• Renal or hepatic failure
• Thiamine deficiency
• Severe infections:
cholera, malaria
• Drugs/toxins:
Biguanides, ethanol,
isoniazid, methanol
28. Clinical Manifestations
1. Tachycardia & Hypotension.
2. Poor skin turgor and dry skin
3. Hypothermia
4. Hyperpnea or Kussmaul breathing
5. Findings associated with coexisting
medical problems (e.g., renal disease,
cardiovascular disease)
29. Laboratory Diagnosis
Arterial blood gas analysis: Metabolic
acidosis with usually high anion gap.
Normal anion gap lactic acidosis has also
been reported.
Blood lactate levels:
• >2 mEq/L : abnormal
• >4 mEq/L: more prognostic value in sepsis
30. Management
• Correct the underlying metabolic abnormality.
• Alkali therapy is of questionable value.
• HCO3 generates CO2 & lowers the intracellular &
CSF pH
• blood lactate levels
• If pH < 7.1 & the patient deteriorating rapidly, a
trial of bicarbonate therapy by administering 1/2
of the estimated bicarbonate deficit
[= 0.6 x wt in kg (15- measured HCO3 )]
• Final aim: to maintain HCO3 level at 15 mEq/L by
bicarbonate therapy
33. Introduction
• Whipple’s triad:
(1) symptoms consistent with hypoglycemia
(2) a low plasma glucose concentration measured with a
precise method (not a glucose monitor)
(3) relief of symptoms after the plasma glucose level is raised
45. References
• Harrison’s Principles of Internal Medicine 19th edition
• Williams Textbook of Endocrinology 13th ed. - S. Melmed, et.
al., (Saunders, 2011)
• Handbook of Diabetes 4th ed - R. Bilous, R. Donnelly (Wiley-
Blackwell, 2010)
• Paul Marino, The ICU book 3rd edition
• Guidelines of American Diabetic Association
• Gosmanov et al Diabetes, Metabolic Syndrome and Obesity:
Targets and Therapy 2014:7 255-264
• Wittlesey, Case study: Diabetes Ketoacidosis complications in
Type 2 Diabetes: Clinical Diabetes Vol. 18 No.2 Spring 2000
• Diabetes Care Volume 27 Supplement 1, January 2004
Editor's Notes
Protocol for the management of adult patients with DKA. *DKA diagnostic criteria: blood glucose >250 mg/dl, arterial pH <7.3, bicarbonate <15 mEq/l, and moderate ketonuria or ketonemia. Normal ranges vary by lab; check local lab normal ranges for all electrolytes. †After history and physical examination, obtain arterial blood gases, complete blood count with differential, urinalysis, blood glucose, blood urea nitrogen (BUN), electrolytes, chemistry profile, and creatinine levels STAT as well as an electrocardiogram. Obtain chest X-ray and cultures as needed. ‡Serum Na should be corrected for hyperglycemia (for each 100 mg/dl glucose >100 mg/dl, add 1.6 mEq to sodium value for corrected serum sodium value). IM, intramuscular; IV, intravenous; SC subcutaneous.
Protocol for the management of pediatric patients (<20 years) with DKA or HHS. *DKA diagnostic criteria: blood glucose >250 mg/dl, venous pH <7.3, bicarbonate <15 mEq/l, moderate ketonuria or ketonemia.†HHS diagnostic criteria: blood glucose >600 mg/dl, venous pH >7.3, bicarbonate >15 mEq/l, and altered mental status or severe dehydration. ‡After the initial history and physical examination, obtain blood glucose, venous blood gases, electrolytes, blood urea nitrogen (BUN), creatinine, calcium, phosphorous, and urine analysis STAT. §sUsually 1.5 times the 24 h maintenance requirements (∼5 ml · kg−1 · h−1) will accomplish a smooth rehydration; do not exceed two times the maintenance requirement. ‖The potassium in solution should be 1/3 KPO4 and 2/3 KCl or K acetate. IM, intramuscular; IV, intravenous; SC subcutaneous.
Protocol for the management of adult patients with HHS. *Diagnostic criteria: blood glucose >600 mg/dl, arterial pH >7.3, bicarbonate >15 mEq/l, mild ketonuria or ketonemia, and effective serum osmolality >320 mOsm/kg H2O. This protocol is for patients admitted with mental status change or severe dehydration who require admission to an intensive care unit. For less severe cases, see text for management guidelines. Normal ranges vary by lab; check local lab normal ranges for all electrolytes. Effective serum osmolality calculation: 2[measured Na (mEq/l)] + glucose (mg/dl)/18. †After history and physical examination, obtain arterial blood gases, complete blood count with differential, urinalysis, plasma glucose, blood urea nitrogen (BUN), electrolytes, chemistry profile, and creatinine levels STAT as well as an electrocardiogram. Obtain chest X-ray and cultures as needed. ‡Serum Na should be corrected for hyperglycemia (for each 100 mg/dl glucose >100 mg/dl, add 1.6 mEq to sodium value for corrected serum value). IV, intravenous; SC subcutaneous.
DKA/HHS flowsheet for the documentation of clinical parameters, fluid and electrolytes, laboratory values, insulin therapy, and urinary output. From Kitabchi et al. (14).